AVITA Medical (RCEL) Consolidated Net Income (2018 - 2025)

AVITA Medical has reported Consolidated Net Income for 8 years, with the latest figure at -$11.6 million in Q4 2025.

• For the quarter ending Q4 2025, Consolidated Net Income changed 0.39% year-over-year to -$11.6 million; the trailing twelve-month figure through Dec 2025 stood at -$48.6 million (up 21.42% YoY), and the FY2025 full-year result was -$48.6 million, up 21.42% from the prior year.
• Consolidated Net Income for Q4 2025 stood at -$11.6 million, up from -$13.2 million in the prior quarter.
• The five-year high for Consolidated Net Income was $37.6 million in Q4 2023, with the low at -$18.7 million in Q1 2024.
• Historically, Consolidated Net Income has averaged -$7.7 million across 5 years, with a median of -$9.7 million in 2022.
• Annual changes were most pronounced in 2023 — Consolidated Net Income jumped 785.6% — and 2024, when it plunged 130.77%.
• AVITA Medical's Consolidated Net Income stood at -$5.9 million in 2021, then increased by 7.73% to -$5.5 million in 2022, then jumped by 785.6% to $37.6 million in 2023, then sank by 130.77% to -$11.6 million in 2024, then dropped by 0.39% to -$11.6 million in 2025.
• The last three Consolidated Net Income figures came in at -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025), per Business Quant data.